Keymed Biosciences Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-515.24	-359.36	-308.12	-3,887
Depreciation & Amortization	91.84	68.78	35.79	20.94
Other Amortization	1.39	0.39	0.34	0.08
Loss (Gain) From Sale of Assets	1.08	0.07	0.39	0.71
Loss (Gain) on Equity Investments	5.26	4.75	9.71	0.72
Stock-Based Compensation	34.35	40.08	48.57	116.82
Other Operating Activities	-81.49	-78.62	-182.94	3,531
Change in Accounts Receivable	-35.76	-27.09	3.98	-3.98
Change in Inventory	-55.07	-11.86	-28.1	-9.55
Change in Accounts Payable	-3.48	14.58	12.13	-0.63
Change in Unearned Revenue	-0.45	-0.81	-	-7
Change in Income Taxes	-6.19	-1.32	-	-
Change in Other Net Operating Assets	-34.04	46.8	6.32	23.99
Operating Cash Flow	-789.63	-303.62	-401.93	-214.64
Capital Expenditures	-207.91	-378.49	-278.82	-171.79
Sale (Purchase) of Intangibles	-6.58	-4.12	-0.73	-1.07
Investment in Securities	162.4	700.46	-575.02	-1,870
Other Investing Activities	119.8	150.35	208.98	6.95
Investing Cash Flow	67.71	468.2	-645.59	-2,036
Long-Term Debt Issued	468.79	360	89.95	-
Total Debt Issued	468.79	360	89.95	-
Short-Term Debt Repaid	-	-0.23	-0.33	-41.82
Long-Term Debt Repaid	-135.55	-93.66	-14.52	-12.91
Total Debt Repaid	-135.55	-93.88	-14.85	-54.73
Net Debt Issued (Repaid)	333.24	266.12	75.1	-54.73
Issuance of Common Stock	-	-	-	2,888
Repurchase of Common Stock	-32.43	-32.9	-51.14	-
Other Financing Activities	-16.91	-161.09	-32.03	-8.5
Financing Cash Flow	283.9	72.13	-8.06	3,638
Foreign Exchange Rate Adjustments	5.41	10.25	139.03	-66.65
Net Cash Flow	-432.62	246.96	-916.55	1,321
Free Cash Flow	-997.55	-682.11	-680.76	-386.42
Free Cash Flow Margin	-233.00%	-192.63%	-680.33%	-350.44%
Free Cash Flow Per Share	-3.81	-2.61	-2.61	-2.40
Cash Interest Paid	18.15	10.49	1.85	-
Levered Free Cash Flow	-565.77	-714.05	-410.26	-231.71
Unlevered Free Cash Flow	-554.23	-703.27	-405.01	-224.75
Change in Working Capital	-326.82	20.29	-5.67	2.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.